Meta-analysis: risk of fractures with acid-suppressing medication

Chun Shing Kwok; Jessica Ka-Yan Yeong; Yoon Kong Loke

doi:10.1016/j.bone.2010.12.015

Meta-analysis: risk of fractures with acid-suppressing medication

Chun Shing Kwok, Jessica Ka-Yan Yeong, Yoon Kong Loke

Research output: Contribution to journal › Article › peer-review

112 Citations (Scopus)

Abstract

Recent studies have suggested an increased risk of fractures with proton pump inhibitors (PPIs) and histamine-2 receptor antagonists (H2RAs). We planned to perform a meta-analysis of fractures in patients taking PPIs and H2RAs.

Original language	English
Pages (from-to)	768-76
Number of pages	9
Journal	Bone
Volume	48
Issue number	4
DOIs	https://doi.org/10.1016/j.bone.2010.12.015
Publication status	Published - 1 Apr 2011

Keywords

Fractures, Bone
Histamine H2 Antagonists
Humans
Odds Ratio
Proton Pump Inhibitors
Risk Factors

Access to Document

10.1016/j.bone.2010.12.015

Cite this

@article{74e18ecdcd614995858311a69eeabbc0,

title = "Meta-analysis: risk of fractures with acid-suppressing medication",

abstract = "Recent studies have suggested an increased risk of fractures with proton pump inhibitors (PPIs) and histamine-2 receptor antagonists (H2RAs). We planned to perform a meta-analysis of fractures in patients taking PPIs and H2RAs.",

keywords = "Fractures, Bone, Histamine H2 Antagonists, Humans, Odds Ratio, Proton Pump Inhibitors, Risk Factors",

author = "Kwok, {Chun Shing} and Yeong, {Jessica Ka-Yan} and Loke, {Yoon Kong}",

year = "2011",

month = apr,

day = "1",

doi = "10.1016/j.bone.2010.12.015",

language = "English",

volume = "48",

pages = "768--76",

journal = "Bone",

issn = "8756-3282",

publisher = "Elsevier",

number = "4",

}

TY - JOUR

T1 - Meta-analysis

T2 - risk of fractures with acid-suppressing medication

AU - Kwok, Chun Shing

AU - Yeong, Jessica Ka-Yan

AU - Loke, Yoon Kong

PY - 2011/4/1

Y1 - 2011/4/1

N2 - Recent studies have suggested an increased risk of fractures with proton pump inhibitors (PPIs) and histamine-2 receptor antagonists (H2RAs). We planned to perform a meta-analysis of fractures in patients taking PPIs and H2RAs.

AB - Recent studies have suggested an increased risk of fractures with proton pump inhibitors (PPIs) and histamine-2 receptor antagonists (H2RAs). We planned to perform a meta-analysis of fractures in patients taking PPIs and H2RAs.

KW - Fractures, Bone

KW - Histamine H2 Antagonists

KW - Humans

KW - Odds Ratio

KW - Proton Pump Inhibitors

KW - Risk Factors

U2 - 10.1016/j.bone.2010.12.015

DO - 10.1016/j.bone.2010.12.015

M3 - Article

C2 - 21185417

VL - 48

SP - 768

EP - 776

JO - Bone

JF - Bone

SN - 8756-3282

IS - 4

ER -